Drug Information

Drug General Information
Drug ID
D0C7LR
Former ID
DNC000881
Drug Name
LLZ16406
Drug Type
Small molecular drug
Indication Discovery agent Investigative [535353]
Formula
ClH
Canonical SMILES
Cl
InChI
1S/ClH/h1H
InChIKey
VEXZGXHMUGYJMC-UHFFFAOYSA-N
CAS Number
CAS 69-05-6
PubChem Compound ID
313
PubChem Substance ID
2784, 4538, 118215, 818580, 5611550, 7849119, 7886642, 8143967, 8150572, 10535191, 15119557, 24438689, 24845468, 24846013, 24846014, 24846154, 24850321, 24850804, 24850806, 24850807, 24855631, 24857783, 24858565, 24858567, 24858569, 24858572, 24858879, 24858880, 24858881, 24859260, 24860627, 24861105, 24861655, 24861656, 24861657, 24861658, 24861660, 24861661, 24861728, 24861799, 24861810, 24863721, 24863912, 24863914, 24863915, 24863916, 24863917, 24863918, 24863919, 24865075
Target and Pathway
Target(s) MEKK-1 kinase Target Info Inhibitor [535353]
KEGG Pathway MAPK signaling pathway
Ubiquitin mediated proteolysis
RIG-I-like receptor signaling pathway
Neurotrophin signaling pathway
GnRH signaling pathway
Hepatitis B
HTLV-I infection
PANTHER Pathway Angiogenesis
Apoptosis signaling pathway
T cell activation
Ras Pathway
Pathway Interaction Database Fc-epsilon receptor I signaling in mast cells
BCR signaling pathway
p38 MAPK signaling pathway
CD40/CD40L signaling
Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)
Osteopontin-mediated events
TRAIL signaling pathway
CDC42 signaling events
FAS (CD95) signaling pathway
Role of Calcineurin-dependent NFAT signaling in lymphocytes
TNF receptor signaling pathway
Ceramide signaling pathway
IFN-gamma pathway
ErbB1 downstream signaling
JNK signaling in the CD4+ TCR pathway
Caspase Cascade in Apoptosis
Regulation of cytoplasmic and nuclear SMAD2/3 signaling
RAC1 signaling pathway
PathWhiz Pathway Intracellular Signalling Through Adenosine Receptor A2a and Adenosine
Intracellular Signalling Through Adenosine Receptor A2b and Adenosine
Reactome MyD88:Mal cascade initiated on plasma membrane
FCERI mediated MAPK activation
TRAF6 mediated NF-kB activation
TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation
MyD88 cascade initiated on plasma membrane
WikiPathways Serotonin HTR1 Group and FOS Pathway
DNA Damage Response (only ATM dependent)
Interferon type I signaling pathways
Insulin Signaling
EGF/EGFR Signaling Pathway
MAPK Cascade
p38 MAPK Signaling Pathway
Apoptosis Modulation by HSP70
MAPK Signaling Pathway
FAS pathway and Stress induction of HSP regulation
MyD88 cascade initiated on plasma membrane
Cardiac Hypertrophic Response
MyD88 dependent cascade initiated on endosome
MyD88:Mal cascade initiated on plasma membrane
Fc epsilon receptor (FCERI) signaling
Structural Pathway of Interleukin 1 (IL-1)
Polycystic Kidney Disease Pathway
Apoptosis
PDGF Pathway
BDNF signaling pathway
TNF alpha Signaling Pathway
IL-1 signaling pathway
RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
References
Ref 535353Pharmacological inhibitors of MAPK pathways. Trends Pharmacol Sci. 2002 Jan;23(1):40-5.
Ref 535353Pharmacological inhibitors of MAPK pathways. Trends Pharmacol Sci. 2002 Jan;23(1):40-5.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.